Physician profile
Steven Weiss
NPI 1730185299
$5,554.56
in general payments reported to CMS, 2019-2025
41 companies · $804 in 2025
The $804 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $609 · 2021: $402 · 2022: $86.54 · 2023: $1,319 · 2024: $1,036 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,838 · Education: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.51 |
| Education | $321.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,104.75 | 2019-2025 | Erleada, Darzalex, Talvey |
| Pfizer INC. | $965.75 | 2019-2025 | |
| Genzyme Corporation | $386.07 | 2019-2025 | |
| Seagen INC. | $338.44 | 2021-2025 | Tukysa, Adcetris, Padcev |
| Novartis Pharmaceuticals Corporation | $237.73 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $232.74 | 2019-2025 | Keytruda, Lynparza |
| Array Biopharma INC | $220.95 | 2020-2024 | Braftovi, Mektovi, Lorbrena |
| Takeda Pharmaceuticals U.S.A., INC. | $162.87 | 2023-2025 | Vpriv, Alunbrig |
| E.R. Squibb & Sons, L.L.C. | $146.29 | 2019-2021 | |
| Lilly USA, LLC | $136.93 | 2019-2025 | Verzenio, Jaypirca |
| Adaptive Biotechnologies Corporation | $127.18 | 2023-2025 | Clonoseq |
| Amgen INC. | $122.52 | 2019-2021 | |
| Daiichi Sankyo INC. | $114.15 | 2020-2024 | Enhertu |
| Astrazeneca Pharmaceuticals Lp | $112.68 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.19 | 2019-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.